Study shows strong long-term survival rates for patients with GIST

Nearly one in four patients with incurable gastrointestinal stromal tumors (GIST) treated with Gleevec will survive 10 years, a new report outlines.

Source: ScienceDaily Headlines - February 20, 2017 Category: Science Source Type: news